Sequencing Therapeutics for Severe and Chronic Immune Thrombocytopenia

Adding Quality of Life to Treatment Goals in Immune Thrombocytopenia

During a roundtable event, Amit R. Mehta, MD, and participants discussed treatment selection for a patient with immune thrombocytopenia whose quality of life is impaired even as her platelet count recovers.

Evaluating Platelet- vs Immune-Directed Therapies in Immune Thrombocytopenia

During a roundtable event, Amit R. Mehta, MD, and participants discussed treatment selection for a patient with immune thrombocytopenia at risk of thrombotic events.

Strategies Shift Beyond Traditional Management of Immune Thrombocytopenia

Adam Cuker, MD, MS, and Amit R. Mehta, MD, discuss the changing treatment landscape and patients goals when treating chronic immune thrombocytopenia.

The Evolution of Treatment Goals in Immune Thrombocytopenia

Adam Cuker, MD, MS, discusses how the goals of treatment for immune thrombocytopenia have developed beyond managing platelet count.